Cargando…
Does Cardiac Contractility Modulation Therapy Reduce Atrial Fibrillation Burden?
Cardiac contractility modulation (CCM) is an implantable technology approved by the U.S. Food and Drug Administration and intended for heart failure patients without a cardiac resynchronization therapy indication. CCM leads to reduced heart failure hospitalizations and improvements in exercise toler...
Autores principales: | Shin, Jae Wook, Atoot, Rami, Heyer, Marissa, Jamal, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635568/ https://www.ncbi.nlm.nih.gov/pubmed/36605296 http://dx.doi.org/10.19102/icrm.2022.13104 |
Ejemplares similares
-
Surgical Treatment of Concomitant Atrial Fibrillation: Focus onto Atrial Contractility
por: Loardi, Claudia, et al.
Publicado: (2015) -
The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation
por: Tobón, Catalina, et al.
Publicado: (2019) -
Does Coffee Reduce the Risk of Atrial Fibrillation?
por: Aleong, Ryan G., et al.
Publicado: (2019) -
Atrial contractile function and fibrosis in patients with paroxysmal atrial fibrillation in sinus rhythm
por: Yaroslav, Ashikhmin, et al.
Publicado: (2022) -
Does Minimal Invasive Cardiac Surgery Reduce the Incidence of Post-operative Atrial Fibrillation?
por: Maimari, Maria, et al.
Publicado: (2020)